Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian Willoughby is active.

Publication


Featured researches published by Brian Willoughby.


AIDS | 1989

Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

M. T. Schechter; Kevin J. P. Craib; Thinh N. Le; Brian Willoughby; B. Douglas; Philip Sestak; Julio S. G. Montaner; Weaver Ms; Elmslie Kd; M. V. O'shaughnessy

As part of an ongoing prospective study of seropositive homosexual men in Vancouver, Canada, a seroprevalent cohort of 246 subjects (i.e. duration of infection unknown) and a seroincident cohort of 102 subjects (i.e. duration of infection known) were followed a median of 63 and 45 months, respectively. Follow-up with validation utilizing record linkage with the Canadian Federal Centre for AIDS registry revealed 58 and nine cases of AIDS in the seroprevalent and seroincident cohorts, respectively, through July 1988. These data yield product limit estimates of the cumulative progression rates to AIDS at 60 months of 23.0% for the seroprevalent cohort, 13.0% for the seroincident cohort, and 21.0% for the combined groups. Univariate analyses revealed the following to be statistically and clinically significant predictors of AIDS progression: low CD4 counts, low CD4/CD8 ratios, elevated immune complexes, elevated immunoglobulin G (IgG) and immunoglobulin A (IgA) levels, and low platelet counts. Cox regression revealed that elevated IgA levels, low CD4 counts, elevated immune complexes, two or more symptoms, and more than 20 male sexual partners in high-risk areas in the 5 years prior to enrollment were independent predictors of progression to AIDS over the subsequent 5 years. A multivariate risk function based on the latter five variables delineated low-, medium- and high-risk groups whose 5-year progression rates to AIDS were 6.7, 15.6 and 64.4%, respectively. The high-risk group contained 75% of all subjects who progressed to AIDS. Only 6% of the high-risk group would have qualified for zidovudine therapy under current guidelines at the beginning of the observation period.(ABSTRACT TRUNCATED AT 250 WORDS)


AIDS | 1990

Susceptibility to AIDS progression appears early in HIV infection.

Martin T. Schechter; Kevin J. P. Craib; Thinh N. Le; Julio S. G. Montaner; B. Douglas; Philip Sestak; Brian Willoughby; Michael V. O'Shaughnessy

To investigate whether predictors of AIDS progression are operative very early in the natural history of HIV infection, we conducted a nested case-control study within a cohort of 119 subjects who seroconverted while under observation in a prospective study of homosexual men. For each of the 18 cases who have progressed to AIDS, we randomly Selected three controls who had seroconverted within 3 months of the case but who have remained AIDS-free. Cases and controls were compared with regard to laboratory and clinical parameters obtained at the time of the earliest HIV-positive result. The median duration between the estimated date of seroconversion and this first positive result was 4 months for cases and 6 months for controls. Cases exhibited lower CD4 counts (657 versus 774 × 106/I; P = 0.037), lower CD4:CD8 ratios (0.98 versus 1.39; P = 0.003), higher immune complex levels (C1q binding: 25 versus 15%; P = 0.002), lower hemaglobin concentrations (14.8 versus 15.2 g/l; P = 0.011), higher immunoglobulin (lg) A levels (272 versus 184mg/dl; P = 0.003), and higher lgG levels (1530 versus 1300mg/dl; P = 0.037) than controls. Cases exhibited higher CD8 counts of marginal statistical significance (732 versus 597 × 1.06/I; P = 0.059). No differences were observed with respect to lgM levels, total lymphocyte or white blood cell counts, or the frequency of generalized lymphadenopathy. A total of 27.8% of cases but only 11.5% of controls reported one or more symptoms during the 6-month period preceding the first positive visit (P = 0.027). We conclude that laboratory and clinical abnormalities which are predictive of more rapid progression to AIDS may appear very early in HIV infection. This suggests that some of the factors responsible for more rapid disease progression are present in the host prior to or shortly after infection occurs.


The Lancet | 1984

CHANGES IN SEXUAL BEHAVIOUR AND FEAR OF AIDS

Martin T. Schechter; E. Jeffries; P. Constance; Douglas B; S. Fay; M. Maynard; R. Nitz; Brian Willoughby; W.J. Boyko; MacLeod A

A high number of sexual partners is strongly associated with the development of the acquired immunodeficiency syndrome (AIDS) in homosexual men. We are conducting a cohort study in 800 homosexual males in Vancouver. Recruitment was done between November 1982 and February 1984 through 6 general practices which cater entirely or predominantly for homosexual men. Volunteers completed a self-administered questionnaire at the time of enrollment giving demographic historical and lifestyle information. Questions about sexual practices were posed in the widely used vernacular. A 2nd questionnaire was administered at least 3 months later at the 1st follow-up visit. The 2nd questionnaire asked about changes in sexual practice since enrollment in the study. So far we have follow-up data for 388 men. Over half reported a decrease in the number of sexual partners. The proportion of respondents reporting no more than 5 partners per year rose from 21% to 37%. Specific sexual practices were more likely to have decreased than increased except for oral-genital contact. This is more striking for the 4 less popular sexual activities than for anal intercourse. Golubjanikov et al. have noted a decline in number of sexual partners for a clinic-based homosexual population in Wisconsin. Our population recruited through general practitioners with an enrollment rate of 95% among those asked to participate is likely to be fairly representative of the homosexual community. However the mere fact of participation in an AIDS-related study might have had an educational effect and the observed changes may be inflated. Nevertheless the evidence points to a decline in overall sexual activity and also in certain specific activities a selectivity that might stem from differences in risk of AIDS as perceived by homosexuals. It is not clear if a decrease in sexual activity is related to the recent decline in the incidence of AIDS. (full text)


Canadian Medical Association Journal | 1986

The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men

M. T. Schechter; W. J. Boyko; B. Douglas; Brian Willoughby; A. McLeod; M. Maynard; Kevin J. P. Craib; M. V. O'shaughnessy


Canadian Medical Association Journal | 1985

The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody

E. Jeffries; Brian Willoughby; W. J. Boyko; Martin T. Schechter; Barry Wiggs; Sean Fay; Michael V. O'Shaughnessy


The Lancet | 1986

CAN HTLV-III BE TRANSMITTED ORALLY?

M. T. Schechter; WilliamJ. Boyko; B. Douglas; M. Maynard; Brian Willoughby; Alistair Mcleod; K. J. P. Craib


AIDS | 1987

Effects of long-term seropositivity to human immunodeficiency virus in a cohort of homosexual men.

M. T. Schechter; Boyko Wj; Kevin J. P. Craib; McLeod A; Brian Willoughby; B. Douglas; Constance P; O'Shaughnessey M


Canadian Medical Association Journal | 1985

The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy

Martin T. Schechter; W. J. Boyko; E. Jeffries; Brian Willoughby; Rod Nitz; Peter Constance


Canadian Medical Association Journal | 1985

The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells

Martin T. Schechter; W. J. Boyko; E. Jeffries; Brian Willoughby; R. Nitz; P. Constance; M. Weaver; B. Wiggs; Michael V. O'Shaughnessy


The Lancet | 1989

INFLUENCE OF ZIDOVUDINE ON PROGRESSION TO AIDS IN COHORT STUDIES

M. T. Schechter; K. J. P. Craib; ThinhN. Le; J. S. G. Montaner; W. Alastair McLeod; Brian Willoughby; KimberlyD. Elmslie; M. V. O'shaughnessy

Collaboration


Dive into the Brian Willoughby's collaboration.

Top Co-Authors

Avatar

Martin T. Schechter

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Kevin J. P. Craib

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

M. T. Schechter

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julio S. G. Montaner

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

M. V. O'shaughnessy

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

K. J. P. Craib

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Thinh N. Le

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

W. Alastair McLeod

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

J. S. G. Montaner

University of British Columbia

View shared research outputs
Researchain Logo
Decentralizing Knowledge